<DOC>
	<DOCNO>NCT02299544</DOCNO>
	<brief_summary>BlueWind system safety performance treatment patient diagnose overactive bladder ( OAB )</brief_summary>
	<brief_title>BlueWind Medical System Treatment Patients With OAB</brief_title>
	<detailed_description>BlueWind Medical system safety performance treatment patient diagnose overactive bladder ( OAB )</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Signed write informed consent . Male female age 18 80 . Patient agree attend followup evaluation willing completely accurately fill void diary questionnaire , willing complete require exams test . Patients overactive bladder symptom : Urinary frequency great 8 times/24 hour AND/OR Urinary urgency leak least 2 leak 3 day void diary Patient fail conservative treatment least 6 month treatment Patients normally function upper urinary tract . Patients clinical evidence neurological S2S4 motor sensory deficit . Prior PTNS Group : Patients successful PTNS treatment ( successful treatment define ≥50 % reduction urinary frequency , and/or ≥50 % few incontinence episode , return normal voiding frequency [ &lt; 8 voids/day ] , base retrospective diary review ) . De novo Patient Group : Patient pass BlueWind compatibility test . Any metal implant area BlueWind Medical implantation site . Patients stable OAB medication least 30 day . Patients receive botulinum toxin injection within past 6 month . Previous urinary incontinence surgery implantation artificial graft material within last 6 month . Any spinal genitourinary surgery within last 6 month . Pelvic pain disorder Obvious clinically demonstrate genuine stress incontinence . Any neurological disease disorder include neuropathy injury result neuropathy . Current urinary tract infection , presence urinary stone and/or urinary tract malignancy ( i.e . tumor , vesicourethral reflux , etc . ) Pelvic radiotherapy chemotherapy . Severe uncontrolled diabetes . Patients anticipate magnetic resonance imaging ( MRI ) exam . Presence cystocele , enterocele rectocele grade 3 4 . Prior PTNS Group : Patients receive concomitant nerve stimulation therapy OAB treatment , except PTNS maintenance therapy . De novo Patient Group : Patients receive receive nerve stimulation therapy OAB treatment , include PTNS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>